Drug Delivery and Targeting

Inbunden, Engelska, 2024

AvMonika Schäfer-Korting,Ulrich S. Schubert,Monika Schafer-Korting

2 569 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

197 in 2010 there have been important advances in drug development, drug delivery and – more recently – drug targeting. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too.

Produktinformation

Utgivningsdatum2024-03-30
Mått155 x 235 x 27 mm
Vikt876 g
FormatInbunden
SpråkEngelska
SerieHandbook of Experimental Pharmacology
Antal sidor411
FörlagSpringer International Publishing AG
ISBN9783031528637

Tillhör följande kategorier

Apotek och farmaceuter inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Farmakologi inom Medicin

Part I. Nanoparticles and other Advanced Technologies.- Knowledge-based design of multi-functional polymer-based nanoparticles.- Stimuli-responsive non-viral nanoparticles for gene delivery.- Sustainability in drug and nano-particle processing.- Advanced formulation approaches for proteins.- Microneedles and polymer films – delivery of peptides, proteins and nucleic acids.- Advances in vaccine delivery enhancers – small molecules and nanomaterials.- Biodegradable long acting injectables: Platform technology and industrial challenges.- Part II. Visualization Technologies.- Visualization of Nano-carriers and Drugs in Cells and Tissue.- Characterization of drug delivery systems by transmission electron microscopy.- Part III. Target Specific Delivery.- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders.- Interactions of nano-systems with immune cells and cancer cells – a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints.- New therapeutic options in pulmonal diseases – sphingolipids and sphingolipid metabolism.- Molecular therapeutics for pulmonary diseases – the need for drug targeting.- Delivery of mitochondrial RNA.- Part IV. Concerted Actions – Thinking the Drug from the Beginning.- ATMP formulations and delivery.- Preclinical testing and approval of ATMP.- Looking to the future – drug delivery in the prophylaxis and therapy of severe and chronic diseases.